Table 2.
Characteristics | Intervention group: Interrupted surveillance, unit A |
Control group: Continuous surveillance, unit B |
||
---|---|---|---|---|
Adjusted IRR of VAP (95% CI)a | P | Adjusted IRR of VAP (95% CI)a | P | |
Bivariate model | ||||
Trend, per quarter | 0.98 (0.93 to 1.03) | 0.45 | 1.01 (0.97 to 1.05) | 0.69 |
Period | ||||
Before surveillance disruptionb | 1.00 (Ref.) | 1.00 (Ref.) | ||
After surveillance disruptionc | 2.17 (1.05 to 4.47) | 0.036 | 1.37 (0.74 to 2.55) | 0.31 |
Full modeld | ||||
Trend, per quarter | 0.98 (0.92 to 1.04) | 0.43 | 1.02 (0.97 to 1.06) | 0.50 |
Period | ||||
Before surveillance disruptionb | 1.00 (Ref.) | 1.00 (Ref.) | ||
After surveillance disruptionc | 2.31 (1.03 to 5.17) | 0.042 | 1.36 (0.72 to 2.56) | 0.35 |
NOTE: CI, confidence interval; IRR, incidence rate ratio; VAP, ventilator-associated pneumonia. aAfter multivariate Poisson regression. b Period 1 (2004 to 2006). c Period 2 (2007 to 2010). d Adjusted for gender, age, patient origin, immunosuppression, diagnosis category, antibiotics and SAPSII at admission in the unit. The two other variables, trend (per quarter) and period (period 1 vs. period 2), were forced in the model.